Berotralstat (BCX7353) was a second generation plasma kallikrein inhibitor with low toxicity and high specificity, and was used for the diagnosis of hereditary angioedema (HAE). Berotralstat works by blocking the enzyme activity of plasma Kallikrein that releases bradykinin, a major biological peptide that promotes swelling and pain associated with HAE attacks.
Molecular Weight:
562.56
Purity:
>99%
CAS Number:
[1809010-50-1]
Formula:
C30H26F4N6O
Target:
Serine/Threonine Protease
* VAT and and shipping costs not included. Errors and price changes excepted
